ACS Publications. Most Trusted. Most Cited. Most Read
My Activity
CONTENT TYPES

3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure–Activity Relationship Studies, and Enantiospecific Recognition

  • María Majellaro
    María Majellaro
    Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
    Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
  • Willem Jespers
    Willem Jespers
    Department of Cell and Molecular Biology, Uppsala University, SE-75124 Uppsala, Sweden
  • Abel Crespo
    Abel Crespo
    Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
    Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
    More by Abel Crespo
  • María J. Núñez
    María J. Núñez
    SNL, Departamento de Farmacología, Facultade de Medicina, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
  • Silvia Novio
    Silvia Novio
    SNL, Departamento de Farmacología, Facultade de Medicina, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
    More by Silvia Novio
  • Jhonny Azuaje
    Jhonny Azuaje
    Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
    Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
  • Rubén Prieto-Díaz
    Rubén Prieto-Díaz
    Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
    Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
  • Claudia Gioé
    Claudia Gioé
    Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
    Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
  • Belma Alispahic
    Belma Alispahic
    Department of Cell and Molecular Biology, Uppsala University, SE-75124 Uppsala, Sweden
  • José Brea*
    José Brea
    Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
    *Email: [email protected]. Phone: +34 881815459. Fax: +34-8818115474.
    More by José Brea
  • María I. Loza
    María I. Loza
    Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
  • Manuel Freire-Garabal
    Manuel Freire-Garabal
    SNL, Departamento de Farmacología, Facultade de Medicina, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
  • Carlota Garcia-Santiago
    Carlota Garcia-Santiago
    SNL, Departamento de Farmacología, Facultade de Medicina, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
  • Carlos Rodríguez-García
    Carlos Rodríguez-García
    Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
    Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
  • Xerardo García-Mera
    Xerardo García-Mera
    Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
  • Olga Caamaño
    Olga Caamaño
    Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
  • Christian Fernandez-Masaguer
    Christian Fernandez-Masaguer
    Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
  • Javier F. Sardina
    Javier F. Sardina
    Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
  • Angela Stefanachi
    Angela Stefanachi
    Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari ALDO MORO, via Orabona 4, 70125 Bari, Italy
  • Abdelaziz El Maatougui
    Abdelaziz El Maatougui
    Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
    Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
  • Ana Mallo-Abreu
    Ana Mallo-Abreu
    Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
    Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
  • Johan Åqvist
    Johan Åqvist
    Department of Cell and Molecular Biology, Uppsala University, SE-75124 Uppsala, Sweden
  • Hugo Gutiérrez-de-Terán*
    Hugo Gutiérrez-de-Terán
    Department of Cell and Molecular Biology, Uppsala University, SE-75124 Uppsala, Sweden
    *Email: [email protected]. Phone: +46 18 471 5056. Fax: +46 18 536971.
  • , and 
  • Eddy Sotelo*
    Eddy Sotelo
    Centro Singular de Investigación en Química Biolóxica y Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
    Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
    *Email: [email protected]. Phone: +34 881815732, +34 881814942. Fax: +34-881815704.
    More by Eddy Sotelo
Cite this: J. Med. Chem. 2021, 64, 1, 458–480
Publication Date (Web):December 29, 2020
https://doi.org/10.1021/acs.jmedchem.0c01431
Copyright © 2020 American Chemical Society

    Article Views

    1767

    Altmetric

    -

    Citations

    LEARN ABOUT THESE METRICS
    Read OnlinePDF (10 MB)
    Supporting Info (3)»

    Abstract

    Abstract Image

    We present and thoroughly characterize a large collection of 3,4-dihydropyrimidin-2(1H)-ones as A2BAR antagonists, an emerging strategy in cancer (immuno) therapy. Most compounds selectively bind A2BAR, with a number of potent and selective antagonists further confirmed by functional cyclic adenosine monophosphate experiments. The series was analyzed with one of the most exhaustive free energy perturbation studies on a GPCR, obtaining an accurate model of the structure–activity relationship of this chemotype. The stereospecific binding modeled for this scaffold was confirmed by resolving the two most potent ligands [(±)-47, and (±)-38Ki = 10.20 and 23.6 nM, respectively] into their two enantiomers, isolating the affinity on the corresponding (S)-eutomers (Ki = 6.30 and 11.10 nM, respectively). The assessment of the effect in representative cytochromes (CYP3A4 and CYP2D6) demonstrated insignificant inhibitory activity, while in vitro experiments in three prostate cancer cells demonstrated that this pair of compounds exhibits a pronounced antimetastatic effect.

    Supporting Information

    ARTICLE SECTIONS
    Jump To

    The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01431.

    • Molecular formula strings (CSV)

    • Peak summary report (PDF)

    • Computational chemistry; general information; general procedure for Biginelli synthesis; spectroscopic and analytical data for all compounds described; and analytical HPLC chromatograms of AF80 (38) and AF80 (47) (PDF)

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    This article is cited by 16 publications.

    1. Harshitha N Anchan, Prajwal Naik C, Navya Subray Bhat, Muskan Kumari, Saikat Dutta. Efficient Synthesis of Novel Biginelli and Hantzsch Products Sourced from Biorenewable Furfurals Using Gluconic Acid Aqueous Solution as the Green Organocatalyst. ACS Omega 2023, 8 (37) , 34077-34083. https://doi.org/10.1021/acsomega.3c05106
    2. Ingo Muegge, Yuan Hu. Recent Advances in Alchemical Binding Free Energy Calculations for Drug Discovery. ACS Medicinal Chemistry Letters 2023, 14 (3) , 244-250. https://doi.org/10.1021/acsmedchemlett.2c00541
    3. Rubén Prieto-Díaz, Manuel González-Gómez, Hugo Fojo-Carballo, Jhonny Azuaje, Abdelaziz El Maatougui, Maria Majellaro, María I. Loza, José Brea, Víctor Fernández-Dueñas, M. Rita Paleo, Alejandro Díaz-Holguín, Beatriz Garcia-Pinel, Ana Mallo-Abreu, Juan C. Estévez, Antonio Andújar-Arias, Xerardo García-Mera, Iria Gomez-Tourino, Francisco Ciruela, Cristian O. Salas, Hugo Gutiérrez-de-Terán, Eddy Sotelo. Exploring the Effect of Halogenation in a Series of Potent and Selective A2B Adenosine Receptor Antagonists. Journal of Medicinal Chemistry 2023, 66 (1) , 890-912. https://doi.org/10.1021/acs.jmedchem.2c01768
    4. Zoe Cournia Christophe Chipot Benoît Roux Darrin M. York Woody Sherman . Free Energy Methods in Drug Discovery—Introduction. , 1-38. https://doi.org/10.1021/bk-2021-1397.ch001
    5. Prabhakara Madivalappa Davanagere, Barnali Maiti. 1,3-Bis(carboxymethyl)imidazolium Chloride as a Sustainable, Recyclable, and Metal-Free Ionic Catalyst for the Biginelli Multicomponent Reaction in Neat Condition. ACS Omega 2021, 6 (40) , 26035-26047. https://doi.org/10.1021/acsomega.1c02976
    6. Stamatia Zavitsanou, Alexandros Tsengenes, Michail Papadourakis, Giorgio Amendola, Alexios Chatzigoulas, Dimitris Dellis, Sandro Cosconati, Zoe Cournia. FEPrepare: A Web-Based Tool for Automating the Setup of Relative Binding Free Energy Calculations. Journal of Chemical Information and Modeling 2021, 61 (9) , 4131-4138. https://doi.org/10.1021/acs.jcim.1c00215
    7. Zhi Li, Lijuan Kou, Xinzhen Fu, Zeping Xie, Maolei Xu, Lin Guo, Tiantian Lin, Shizhou Gong, Shumin Zhang, Ming Liu. Design, synthesis, and biological evaluation of triazole-pyrimidine-methylbenzonitrile derivatives as dual A 2A /A 2B adenosine receptor antagonists. Journal of Enzyme Inhibition and Medicinal Chemistry 2022, 37 (1) , 1514-1526. https://doi.org/10.1080/14756366.2022.2077731
    8. Johannes Karwounopoulos, Marcus Wieder, Stefan Boresch. Relative binding free energy calculations with transformato: A molecular dynamics engine-independent tool. Frontiers in Molecular Biosciences 2022, 9 https://doi.org/10.3389/fmolb.2022.954638
    9. Jorge Barbazán, Maria Majellaro, Antón L. Martínez, José M. Brea, Eddy Sotelo, Miguel Abal. Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR ligands. Biomedicine & Pharmacotherapy 2022, 153 , 113408. https://doi.org/10.1016/j.biopha.2022.113408
    10. Negin Rostami, Mohammad G. Dekamin, Ehsan Valiey, Hamidreza FaniMoghadam. l -Asparagine–EDTA–amide silica-coated MNPs: a highly efficient and nano-ordered multifunctional core–shell organocatalyst for green synthesis of 3,4-dihydropyrimidin-2(1 H )-one compounds. RSC Advances 2022, 12 (34) , 21742-21759. https://doi.org/10.1039/D2RA02935A
    11. Anna Vlachodimou, Henk de Vries, Milena Pasoli, Miranda Goudswaard, Soon-Ai Kim, Yong-Chul Kim, Mirko Scortichini, Melissa Marshall, Joel Linden, Laura H. Heitman, Kenneth A. Jacobson, Adriaan P. IJzerman. Kinetic profiling and functional characterization of 8-phenylxanthine derivatives as A2B adenosine receptor antagonists. Biochemical Pharmacology 2022, 200 , 115027. https://doi.org/10.1016/j.bcp.2022.115027
    12. Adriaan P. IJzerman, Kenneth A. Jacobson, Christa E. Müller, Bruce N. Cronstein, Rodrigo A. Cunha, . International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update. Pharmacological Reviews 2022, 74 (2) , 340-372. https://doi.org/10.1124/pharmrev.121.000445
    13. Jiao Chen, Zhenhua Zhu, Jiali Cai, Mengru Cao, Feng Sha, Sha Tao, Hao Yang, Haifeng Gan, Hongli Wu, Fei Cao, Lili Zhao, Pingkai Ouyang. Application of sugar-containing biomass: one-step synthesis of 2-furylglyoxylic acid and its derivatives from a vitamin C precursor. Green Chemistry 2022, 24 (5) , 2000-2009. https://doi.org/10.1039/D2GC00186A
    14. Isabella Bolognino, Antonio Carrieri, Rosa Purgatorio, Marco Catto, Rocco Caliandro, Benedetta Carrozzini, Benny Danilo Belviso, Maria Majellaro, Eddy Sotelo, Saverio Cellamare, Cosimo Damiano Altomare. Enantiomeric Separation and Molecular Modelling of Bioactive 4-Aryl-3,4-dihydropyrimidin-2(1H)-one Ester Derivatives on Teicoplanin-Based Chiral Stationary Phase. Separations 2022, 9 (1) , 7. https://doi.org/10.3390/separations9010007
    15. Willem Jespers, Laura H. Heitman, Adriaan P. IJzerman, Eddy Sotelo, Gerard J. P. van Westen, Johan Åqvist, Hugo Gutiérrez-de-Terán, . Deciphering conformational selectivity in the A2A adenosine G protein-coupled receptor by free energy simulations. PLOS Computational Biology 2021, 17 (11) , e1009152. https://doi.org/10.1371/journal.pcbi.1009152
    16. Jun‐An Xiao, Hai Peng, Jin‐Shao Liang, Xiao‐Yan Luo, Xiu‐Liang Cheng, Wei Su. Gold‐Catalyzed Tandem Cycloisomerization/Ring Expansion of Alkynyl Spiro‐epoxyoxindoles: Access to Furo[2,3‐c]quinolinone Derivatives. Asian Journal of Organic Chemistry 2021, 10 (6) , 1436-1439. https://doi.org/10.1002/ajoc.202100202

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    MENDELEY PAIRING EXPIRED
    Your Mendeley pairing has expired. Please reconnect